This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of March 2022. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
|Cause area||Count||Median||Mean||Minimum||10th percentile||20th percentile||30th percentile||40th percentile||50th percentile||60th percentile||70th percentile||80th percentile||90th percentile||Maximum|
|Open Philanthropy (filter this donee)||724,929.00||724,929.00|
Graph of top 10 donors by amount, showing the timeframe of donations
|Donor||Amount (current USD)||Amount rank (out of 1)||Donation date||Cause area||URL||Influencer||Notes|
|Open Philanthropy||724,929.00||1||Global health/nutrition||https://www.openphilanthropy.org/giving/grants/project-peanut-butter-ready-use-therapeutic-food-rct||--||Intended use of funds (category): Direct project expenses
Intended use of funds: Grant to support a three-year randomized controlled trial (RCT) on the effect on cognitive development of reformulated ready-to-use therapeutic food (RUTF) with additional omega-3 fatty acids and decreased omega-6 fatty acids, compared to conventional RUTF
Donor reason for selecting the donee: RUTF is primarily used to treat young children in the developing world with severe acute malnutrition. The grant is based on our belief that there is a reasonable chance that increasing the ratio of omega-3 to omega-6 fatty acids in RUTF will have a positive effect on the cognitive development of treated children, and that a clear result in a large randomized trial would be fairly likely to make use of the lipid-rebalanced RUTF standard practice.
Donor reason for donating that amount (rather than a bigger or smaller amount): Likely the estimated cost of running the RCT. No specific amount-related considerations are discussed Intended funding timeframe in months: 36; announced: 2016-10-26.